IN VIVO RELEASE OF FT-207 FROM IRRADIATION POLYMERIZED COMPOSITES
|更新时间:2023-04-07
|
IN VIVO RELEASE OF FT-207 FROM IRRADIATION POLYMERIZED COMPOSITES
Journal of Radiation Research and Radiation ProcessingVol. 17, Issue 1, Pages: 28-30(1999)
作者机构:
1.沈阳军区军事医学研究所 沈阳 110031
2.辽宁省分析测试中心 沈阳 110015
作者简介:
基金信息:
Young Scientific Research Fund of PLA "The Eighth of Five Years Plan"
DOI:
CLC:
扫 描 看 全 文
XIE Huaijiang, KOU Qinghe, SONG Juzhong, et al. IN VIVO RELEASE OF FT-207 FROM IRRADIATION POLYMERIZED COMPOSITES. [J]. Journal of Radiation Research and Radiation Processing 17(1):28-30(1999)
DOI:
XIE Huaijiang, KOU Qinghe, SONG Juzhong, et al. IN VIVO RELEASE OF FT-207 FROM IRRADIATION POLYMERIZED COMPOSITES. [J]. Journal of Radiation Research and Radiation Processing 17(1):28-30(1999)DOI:
IN VIVO RELEASE OF FT-207 FROM IRRADIATION POLYMERIZED COMPOSITES
Polymer-drugs composite with long periods of controlled slow release was made by radiation induced polymerization in room temperature. In experiment in vivo, the composite were implanted subcutaneously the back of rabbits. The concentration of 1- (2-tetrahydrofuryl) -5-fluorouracil (FT-207) was determined by HPLC. The results of test showed that the concentration of serum drug is 1.0,µ,g/mL after 1 week in the polymer-drug composites group. The drug concentration of tissue surrouding the composites is 76.2±10.4,µ,g/mL. The drug concentration in the far organ (e.g.the lung 1.2±0.5,µ,g/mL) is lower than the tissue surrounding the composite. The serum drug is higher and shorter time by the routine methods. The serum concentration of FT-207 is lower and retarded by implanted.